scholarly article | Q13442814 |
P50 | author | Joanna Moncrieff | Q16732770 |
P2093 | author name string | D Cohen | |
J P Mason | |||
P2860 | cites work | Subjective response as a predictor of outcome in pharmacotherapy: the consumer has a point | Q44403262 |
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Internet | Q75 |
P304 | page(s) | 102-111 | |
P577 | publication date | 2009-02-15 | |
P1433 | published in | Acta Psychiatrica Scandinavica | Q4033348 |
P1476 | title | The subjective experience of taking antipsychotic medication: a content analysis of Internet data | |
P478 | volume | 120 |
Q36438771 | Acceptance-based Behavior Therapy for Depression With Psychosis: Results From a Pilot Feasibility Randomized Controlled Trial |
Q26824283 | Adverse Drug Reaction Identification and Extraction in Social Media: A Scoping Review |
Q39447168 | Adverse event assessment methods in published trials of psychotropic drugs: Poor reporting and neglect of emerging safety concerns |
Q34488215 | Antipsychotic Maintenance Treatment: Time to Rethink? |
Q92476399 | Antipsychotic drugs: from 'major tranquilizers' to Neuroscience-based-Nomenclature |
Q38023499 | Antipsychotic medications, psychological side effects and treatment engagement |
Q53092564 | Antipsychotics decrease response confidence. |
Q39305714 | Are there associations among physical activity, fatigue, sleep quality and pain in people with mental illness? A pilot study. |
Q42015192 | Assessment of Web-Based Consumer Reviews as a Resource for Drug Performance. |
Q36582018 | Behavioral and emotional adverse events of drugs frequently used in the treatment of bipolar disorders: clinical and theoretical implications |
Q35567642 | Can online consumers contribute to drug knowledge? A mixed-methods comparison of consumer-generated and professionally controlled psychotropic medication information on the internet |
Q37986695 | Cognitive impairment associated with schizophrenia: a review of the humanistic burden |
Q95386203 | Cognitive therapy for people with a schizophrenia spectrum diagnosis not taking antipsychotic medication: an exploratory trial |
Q50660859 | Cognitive therapy for people with schizophrenia spectrum disorders not taking antipsychotic drugs: a single-blind randomised controlled trial. |
Q51815334 | Consumer strategies for coping with antipsychotic medication side effects. |
Q55109854 | Descriptions of Adverse Drug Reactions Are Less Informative in Forums Than in the French Pharmacovigilance Database but Provide More Unexpected Reactions. |
Q84280631 | Effects of antipsychotic treatment on psychopathology and motor symptoms. A placebo-controlled study in healthy volunteers |
Q34266750 | Effects of drop-out on efficacy estimates in five Cochrane reviews of popular antipsychotics for schizophrenia |
Q57892499 | Engaging People with Psychosis in Acceptance and Commitment Therapy and Mindfulness |
Q50707842 | Excessive dosing and polypharmacy of antipsychotics caused by pro re nata in agitated patients with schizophrenia. |
Q35591334 | How do psychiatric drugs work? |
Q64911126 | Mental health professionals' views and experiences of antipsychotic reduction and discontinuation. |
Q82461273 | Nonaddictive instrumental drug use: Theoretical strengths and weaknesses |
Q92080750 | Positive and Negative Effects of Antipsychotic Medication: An International Online Survey of 832 Recipients |
Q45937252 | Psychiatrists' accounts of insight. |
Q36284038 | Reaching out to people struggling with their lives: a discourse analysis of answers from Internet-based services in Norway and Sweden |
Q51847447 | Recovering from mental health problems: perceived positive and negative effects of medication on reconnecting with life. |
Q47599889 | Research on a 'drug-centred' approach to psychiatric drug treatment: assessing the impact of mental and behavioural alterations produced by psychiatric drugs |
Q36067721 | Results of a pilot cluster randomised trial of the use of a Medication Review Tool for people taking antipsychotic medication. |
Q36144426 | Struggles for recognition: a content analysis of messages posted on the Internet |
Q27687556 | Systematic review on the prevalence, frequency and comparative value of adverse events data in social media. |
Q34442663 | Text mining for adverse drug events: the promise, challenges, and state of the art. |
Q47633028 | The least worst option: user experiences of antipsychotic medication and lack of involvement in medication decisions in a UK community sample |
Q48318194 | The medicalisation of "ups and downs": the marketing of the new bipolar disorder |
Q33989385 | The psychoactive effects of psychiatric medication: the elephant in the room |
Q38877181 | Translational Value of Drug Discrimination with Typical and Atypical Antipsychotic Drugs |
Q42672233 | Undesirable effects related to oral antineoplastic drugs: comparison between patients' internet narratives and a national pharmacovigilance database |
Q47584841 | Use of Photovoice to Understand the Experience of Taking Psychotropic Medications |
Q89669017 | Using Open Questions to Understand 650 People's Experiences With Antipsychotic Drugs |
Search more.